<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04290351</url>
  </required_header>
  <id_info>
    <org_study_id>hemorrhoids X. study</org_study_id>
    <nct_id>NCT04290351</nct_id>
  </id_info>
  <brief_title>The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids.</brief_title>
  <official_title>Comparative Study of Band Ligation and Phlebotonic Drug Versus Only Phlebotonic Drug, in Bleeding Internal Hemorrhoids.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konya Meram State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konya Meram State Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the researchers planned to compare the treatment results of patients&#xD;
      undergoing rubber band ligation in addition to drug therapy in hemorrhagic internal&#xD;
      hemorrhoids patients and those treated only with anti-hemorrhoidal drugs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Band ligation is one of the most frequently used methods in the treatment of&#xD;
      hemorrhagic internal hemorrhoidal disease. Also, phlebotonic use and surgical excision&#xD;
      options are available as an anti-hemorrhoidal drug in the treatment of the disease. Many&#xD;
      studies have shown that these methods are safe to use. Band ligation is used quite often in&#xD;
      our clinic. Whether or not band ligation is performed, these patients are prescribed&#xD;
      phlebotonics as an anti-hemorrhoidal drug.&#xD;
&#xD;
      Purpose: In this study, investigators aimed to investigate the benefit of adding rubber band&#xD;
      ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti&#xD;
      hemorrhoidal drug.&#xD;
&#xD;
      Method: The study was planned prospectively and observationally. Patients are not assigned to&#xD;
      groups by the researcher. The researcher cannot interfere with the treatment method given to&#xD;
      the patient. The method of treatment is the method approved by the patient's doctor.&#xD;
&#xD;
      Patients diagnosed with internal hemorrhoids will be examined in a group of patients who are&#xD;
      prescribed anti-hemorrhoidal drugs and rubber band ligation in the context of routine&#xD;
      treatment.&#xD;
&#xD;
      In the other group, again, in the form of routine treatment, patients who are not given&#xD;
      rubber band ligation and who are given only anti-hemorrhoidal drugs will be examined.&#xD;
&#xD;
      Group 1: Patients who have been prescribed 450 mg diosmin + 50 mg hesperidin as an&#xD;
      anti-hemorrhoidal drug and rubber band ligation will be included in this group.&#xD;
&#xD;
      Group 2: Patients who have been prescribed only 450 mg of diosmin + 50 mg of hesperidin as&#xD;
      treatment, without rubber band ligation will be included in this group.&#xD;
&#xD;
      Patients will undergo a control examination in the 21 days after treatment.&#xD;
&#xD;
        -  Whether the bleeding continues?&#xD;
&#xD;
        -  Which bleeding day stopped?&#xD;
&#xD;
        -  The comfort of the anal area will be evaluated&#xD;
&#xD;
        -  Did the side effect develop?&#xD;
&#xD;
        -  Did any complications occur? The above information will be entered into the SPSS&#xD;
           program, and statistical analysis will be done.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>hemostasis rate</measure>
    <time_frame>21 days</time_frame>
    <description>At the end of the treatment, the proportion of patients without hemorrhoids bleeding will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemorrhage stopped on the day of treatment.</measure>
    <time_frame>21 days</time_frame>
    <description>It will be determined that the bleeding stops on the day of treatment.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Hemorrhoids, Internal</condition>
  <arm_group>
    <arm_group_label>Band ligation and phlebotonic group</arm_group_label>
    <description>Patients with rubber band ligation and the prescribed anti hemorrhoidal drug will be examined in this group.&#xD;
(Note: The researcher has no contribution or intervention to the treatment method.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Only phlebotonic group</arm_group_label>
    <description>Patients who are prescribed the only 450mg of diosmin + 50mg of hesperidin as a treatment for bleeding internal hemorrhoids will be examined in this group.&#xD;
(Note: The researcher has no contribution or intervention to the treatment method.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>band ligation</intervention_name>
    <description>Rubber band ligation will be applied to patients, and then phlebotonic will be prescribed.&#xD;
(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)</description>
    <arm_group_label>Band ligation and phlebotonic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral 450 mg diosmin+50 mg hesperidin</intervention_name>
    <description>450 mg diosmin + 50 mg hesperidin will be prescribed to patients undergoing band ligation.&#xD;
(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)</description>
    <arm_group_label>Band ligation and phlebotonic group</arm_group_label>
    <arm_group_label>Only phlebotonic group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients between the ages of 18 and 65 who apply to our hospital from Konya and neighboring&#xD;
        provinces and accept the treatments offered, constitute the study population.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with internal hemorrhoids with an anamnesis + examination +&#xD;
             rectoscope.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years old&#xD;
&#xD;
          -  Patients over 65 years old&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Chronic liver patients&#xD;
&#xD;
          -  Those with bleeding disorders&#xD;
&#xD;
          -  Patients taking anti-coagulants and anti-aggregates&#xD;
&#xD;
          -  Patients with colorectal cancer.&#xD;
&#xD;
          -  Those who have had hemorrhoid surgery before&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alpaslan ŞAHİN, MD</last_name>
    <phone>+905052955095</phone>
    <email>drasahin@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gürcan ŞİMŞEK, MD</last_name>
    <phone>+903322210000</phone>
    <phone_ext>7208</phone_ext>
    <email>drgurcansimsek@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Konya Training and Research Hospital</name>
      <address>
        <city>Konya</city>
        <zip>42090</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Alpaslan Şahin, MD</last_name>
      <phone>+905052955095</phone>
      <email>drasahin@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gürcan Şimşek, MD</last_name>
      <phone>+903322210000</phone>
      <phone_ext>7208</phone_ext>
      <email>drgurcansimsek@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Kemal ARSLAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lohsiriwat V. Treatment of hemorrhoids: A coloproctologist's view. World J Gastroenterol. 2015 Aug 21;21(31):9245-52. doi: 10.3748/wjg.v21.i31.9245. Review.</citation>
    <PMID>26309351</PMID>
  </reference>
  <reference>
    <citation>Albuquerque A. Rubber band ligation of hemorrhoids: A guide for complications. World J Gastrointest Surg. 2016 Sep 27;8(9):614-620. Review.</citation>
    <PMID>27721924</PMID>
  </reference>
  <reference>
    <citation>Schleinstein HP, Averbach M, Averbach P, Correa PAFP, Popoutchi P, Rossini LGB. ENDOSCOPIC BAND LIGATION FOR THE TREATMENT OF HEMORRHOIDAL DISEASE. Arq Gastroenterol. 2019 May 20;56(1):22-27. doi: 10.1590/S0004-2803.201900000-15.</citation>
    <PMID>31141063</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>February 25, 2020</study_first_submitted>
  <study_first_submitted_qc>February 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konya Meram State Hospital</investigator_affiliation>
    <investigator_full_name>Alpaslan Şahin</investigator_full_name>
    <investigator_title>principal investigators</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

